What to look for in a life sciences partner

Susie Harborth explores what it takes to be a scientist entrepreneur and highlights the technology driving innovation in bioscience

23 Nov 2020
Tom Casburn
Associate Editor

Editorial article

Susie Harborth, Executive Vice President of Business Operations, Breakthrough Properties

Susie Harborth is the Executive Vice President of Business Operations at Breakthrough Properties, a real estate company dedicated to the provision of world-class spaces for life science communities. Here, Harborth speaks with SelectScience about her company’s goals and explains how a collaboration with PHCbi has been critical to delivering high-quality resources that enable scientist entrepreneurs to develop pioneering therapies, diagnostics and vaccinations.

What are the key goals of your company?

SH: At Breakthrough Properties, we believe that scientist entrepreneurs need innovation ecosystems to support their research. Our goal is to create environments that foster innovation, where discoveries can be made that transform lives. We do this in a number of ways, not only through providing world-class spaces but also access to industry partners, potential capital sources and general peer-to-peer learning. One of the things we think is really important is engaging the community, as supporting entrepreneurs takes a village. We look to connect researchers with this village and its multiple pillars – real estate, funding sources or industry partners like PHCbi, for example.

What challenges does the life sciences industry face?

SH: The life sciences industry faces many challenges, especially in this COVID-19 era, but has proven very resilient during this time of uncertainty. The industry is at the forefront of developing pioneering therapies, diagnostics and vaccinations to advance human health and its main challenges are therefore the multiple factors surrounding the development of these and the potential for failure. I think if we can eliminate friction from innovation, all the way from discovery to patient experience, this will help to elevate and accelerate the development of life-saving therapies.

How has your partnership with PHCbi helped to overcome these challenges?

SH: We’ve had an amazing collaboration with PHCbi over many years and the team has been instrumental in helping us provide entrepreneurial scientists with the best products and services for their groundbreaking research. One of the important things to recognize with PHCbi is its strong legacy as part of the Panasonic family of providing best-in-class products and services. For early-stage researchers, it is critical to get the scientific data right – it’s the currency of their business – so having high-quality products they can rely on is a real gamechanger. PHCbi products are world-class, made with precision engineering, and we rely on them heavily for the research in our labs. We hope we will continue to partner with them in innovative ways for the benefit of human health going forward.

What should an entrepreneurial scientist seek in a partner?

SH: Seeking out mentors, peers and partners who understand or share your entrepreneurial trajectory is really critical. Peer-to-peer collaboration is such an important element of our industry and that’s why we aim to create environments that encourage this. Most importantly, I think you should look for someone who understands what you do, how you do it and why you do it.

At Breakthrough Properties, we want to create the best experience for our tenants through providing a wealth of resources and taking care of all the peripheral services, such as operational facilities and health and safety, as well as connecting scientists with industry partners. PHCbi has been at the forefront of this, supporting our different innovation hubs by bringing the best products to researchers so they can do what they do best – focus on science.

Find out more about Susie Harborth’s work here>>

Do you use PHCbi products in your lab? Write a review today for your chance to win a $400 Amazon gift card>>

Links

Tags

Refrigerators Freezers and CryogenicsRefrigerators, Freezers & Cryogenics can be used for preservation or experimental purposes. Types of freezers include deep freeze, -80C°C, ultra-low temperature, explosion proof, cryogenic and controlled rate freezers. Freezing is also used in freeze-drying equipment for dehydration processes. Feature to consider in freezers include temperature control and recorders, failure alarms and self-closing mechanisms.IncubatorsLaboratory incubators are used to provide a stable environment to cultivate and store samples in, giving you optimal control of temperature, humidity, oxygen and CO<sub>2</sub> levels. Incubators are necessary equipment for cell culture and microbial research. Control temperature with heated or refrigerated incubators, or the levels of CO<sub>2</sub> and oxygen with CO<sub>2</sub> incubators. Using environmental chambers, create a humid climate for testing samples. Find the best incubators in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.CollaborationMolecular DiagnosticsMolecular diagnostics use an individual’s genetic code and gene expression to diagnose and monitor diseases. The technique is used increasingly in the field of infectious diseases and oncology, as well as areas such as coagulation, HLA typing and pharmacogenomics. Molecular diagnostics plays a pivotal role in personalized medicine.Vaccine DevelopmentVaccine development focuses on creating immunizations to protect against infectious diseases. The process involves identifying antigens, developing and testing vaccine efficacy, and ensuring safety through preclinical testing and multiple clinical trial phases. Scientists use various approaches, including weakened or inactivated viruses, protein subunits, or mRNA. Advanced platforms and rapid diagnostic tools aid in vaccine research and testing. Explore vaccine development solutions in our peer-reviewed product directory; compare products, read reviews, and get pricing directly from manufacturers. TherapeuticsTherapeutics are treatments designed to alleviate or cure diseases. These include pharmaceuticals, biologics, and gene therapies, which work by targeting specific disease mechanisms. Advances in personalized medicine and biologics offer new hope for patients with conditions that were previously difficult to treat. Browse our peer-reviewed product directory to find therapeutic solutions for various diseases; compare products, check user reviews, and get pricing directly from manufacturers.